Business Conduct Standards for Interactions with Healthcare Professionals. Pocket Guide for U.S. Sales Professionals. Do The Right Thing
|
|
- Alison Cox
- 8 years ago
- Views:
Transcription
1 Business Conduct Standards for Interactions with Healthcare Professionals Pocket Guide for U.S. Sales Professionals Do The Right Thing
2 As Amgen s Vice President of Sales and Marketing Operations and Planning, Compliance Officer for U.S. Sales and Marketing, and an Amgen staff member for 14 years, I am very proud of our organization s business conduct track record over the last 25 years. As the face of Amgen, ethics and integrity must always be in the forefront of how you conduct business with customers. We ve adopted a new policy entitled Interactions with Healthcare Professionals to clarify how the Do The Right Thing program applies to Sales and Marketing specifically. To make it easy to know how to comply with the letter and spirit of this policy, we ve prepared a series of compliance standards which detail how we do the right things the right way. This field reference guide summarizes the compliance standards and is designed to provide a quick reference in situations that arise when you are on the road. For the complete standards, including definitions of terms referenced throughout this guide, please consult the Compliance section on the MYAMGEN portal or your Business Conduct Standards binder. Michael Savin Vice President Sales and Marketing Operations and Planning This summarized guide should not be viewed as a substitute for learning and abiding by the standards in their entirety.
3 Gifts to Healthcare Professionals Gifts Gifts Defined: Anything of value given by an Amgen employee or agent without payment or without an even exchange of services from the recipient. Gifts do not include items provided to persons who are performing services for Amgen if the items are necessary to the provision of services (e.g., CRA supplies, notebooks and pens to study sites for use in connection with performing data collection for an Amgen study). Standard: Gifts may only be provided by Amgen personnel to Customers in compliance with the principles set forth in this Standard. Under no circumstances may a gift be offered or provided with the intent of, directly or indirectly, influencing or encouraging the recipient to purchase, prescribe, refer, sell, arrange for the purchase or sale, or recommend formulary placement of any Amgen product. Gifts may not be provided in connection with discussions, negotiations, or decisions involving product pricing or purchasing, or formulary status. Marketing-Initiated Reminder Item Programs: Gifts of minimal value (e.g., items such as company or product branded pens, mugs and notepads) may be provided to Customers when they are administered through a headquarters-driven promotional program. Marketing-Initiated Textbook and Premium Item Programs: Textbooks and other patient- or practice-related items (e.g., stethoscopes, anatomical models) may be offered to Customers in accordance with a headquarters-driven program. Items given through such a program should have a retail value of no more than $100. Prohibited Gifts: Cash or cash equivalents (e.g., general gift certificates) Gifts purchased by an Amgen employee, in a manner inconsistent with this Standard, with his/her own funds, even if the employee does not intend to seek reimbursement from Amgen Gifts for the personal benefit of a Customer or a Customer s family member (e.g., clothing, golf balls), even when they bear a company or product logo Gifts of tickets to recreation and entertainment events
4 The provision of samples for a Customer s personal or family use (as opposed to patient use in accordance with the Prescription Drug Marketing Act) Gifts to Government Employees No gifts may be provided to federal, state or other government personnel unless the requirements of the Amgen Dealing with the Government Policy are also met. Annual Gift Limit: With the exception of reminder items, no Customer may receive gifts with a combined total retail value in excess of $150 per year from Amgen. Field Action: Follow headquarters instruction. Manager Responsibility: Managers shall be responsible for monitoring the activities and performance of their respective employees against the requirements set forth in this Standard.
5 Grants and Healthcare Donations by the Medical Education Department Standard: All donations are approved through and funded by the Medical Education department. Donations are grants, contributions or payments, in cash or in kind, made by Amgen, to further an educational, scientific or other charitable purpose, and made to a Qualified Recipient (see below). Grants Amgen may only make Donations to Qualified Recipients for the following purposes: To advance medicine and healthcare To promote healthcare professional education or serve another genuine educational function To educate the public on disease states and medical conditions Other genuine philanthropic and charitable purposes that demonstrate good corporate citizenship and represent a benefit to society. Donations may not be linked, directly or indirectly, to an agreement to use, prescribe, recommend or refer Amgen products or be used to reward past business. Qualified Recipients: Hospitals Universities Patient groups Organizations exempt from federal income tax under Internal Revenue Code Sections 501(c)(3) non-profit organizations, 501(c)(4) social welfare organizations, and 501(c)(6) trade and professional associations. Note: Physicians and individuals are not Qualified Recipients. Decision Making Process: The Donation Review Committee and Medical Education Department must make all funding decisions based on a complete Donation application. Field Action: Sales personnel may not participate in the Donation application or decision making process, but may provide a copy of the approved Donation application form and procedures to individuals and organizations who want to make a Donation request. Sales personnel are not to call the Medical Education Department to inquire about the status of grants.
6 Independent Medical Education Standard: Independent Medical Education (IME) consists of live presentations and/or written, enduring materials that are intended to educate healthcare professionals, and are developed by entities external to Amgen. Independent Medical Education provides valuable education to healthcare professionals. Funding Authority: Amgen s Medical Education Department shall make all decisions concerning funding of IME based on applications that have been submitted to it by third party providers of education. Decision to Support: The decision to support IME should be made on the basis of the program topic only. It should not be made with knowledge of program content, speakers, moderators, etc. Qualified Topics: Amgen generally supports IME that relates to a disease state of interest to the company. Qualifying topics can discuss the disease state generally, or the use of a product class for the treatment of that disease. A topic is not qualified if: No products in the class are indicated for the treatment being discussed, or; The title of the program specifically mentions an off-label use of an Amgen product. Independent Medical Education Program Development: To ensure the content of IME remains independent, Amgen employees must adhere to the following standards concerning program development: Provider Control of Content: Amgen must be hands off, which means Amgen employees may not participate in any aspect of program planning or development. Speakers: The program provider must select the speakers. Materials: Amgen may not offer materials to the provider. Invitations: The program provider is responsible for promotion of its own program. However, the field may be requested by the program provider via marketing to distribute invitations or save the date cards.
7 Attendance by Amgen Employees at Live Events: Amgen employees may attend IME events; however, they may not participate in audience discussions, or ask questions of the presenter. In addition, Amgen employees may not perform any promotional activities including the provision of non-programrelated meals or entertainment in connection with an IME program. Field Action: Follow instructions provided by your marketing team for all IME programs.
8 Meals and Entertainment with Customers Standard: Meals and entertainment may only be provided by Amgen personnel in compliance with this Standard. Under no circumstances may meals or entertainment be offered or provided with the intent of, directly or indirectly, influencing or encouraging the recipient to purchase, prescribe, refer, sell, arrange for the purchase or sale, or recommend formulary placement of any Amgen product. Modest meals may be provided in connection with a legitimate business purpose. Legitimate business purposes include: Informing Customers about the benefits and risks associated with Amgen products. Providing scientific and educational information to Customers as it relates to the clinical areas in which Amgen has ongoing business interests. Obtaining legitimate and valuable feedback and information from a Customer. Negotiating contracts and sale terms. Performing work under a bona fide consulting agreement. Meals Informational presentations and discussions with Customers: Meals may be provided in connection with informational presentations and discussions in a venue and manner conducive to conducting business matters and/or engaging in a scientific or educational exchange of information. No more than four (4) Customers may be present for every Amgen employee in attendance. Entertainment and recreational events may not be offered in connection with these activities. The total cost of such meals, including tax and tip, may not exceed $125 per person. Provision of In-Office Meals: In-office meals may be provided in connection with informational presentations and discussions only where they are modest in amount and occur in a manner conducive to the legitimate purposes set forth above. The total cost of such meals, including tax and tip, may not exceed $30 per targeted healthcare professional and Amgen employee in attendance.
9 Meals Provided in Connection with Amgen Meetings: Attendance at Speaker Programs must be documented, and the meals provided to attendees shall be included in the spending limit, as determined by Amgen (see Field Action). Prohibited Meals & Entertainment: Recreation and entertainment events are prohibited, even where Amgen personnel are present. No meals may be provided in cash or in cash equivalents (e.g., gift certificates for restaurant meals). No meals may be provided where an Amgen employee is not present. An Amgen employee may not provide meals and entertainment, in a manner inconsistent with this Standard, with his/her own funds, even if the employee does not intend to seek reimbursement from Amgen. Inclusion of a Customer s spouse or other guests in meals provided at any informational presentation or reception is not appropriate; therefore spouses and guests should not be invited. This restriction does not apply where Amgen provides a grant to a convention sponsor. Up-Front Verification of Eligibility: Prior to providing a meal to a Customer, Amgen employees must determine the Customer has not yet reached the spending limit. Expense Reporting: All expenses for meals must be recorded in the Amgen employee s expense report consistent with the Amgen General Travel and Expense Policy. In addition, the Amgen employee must record the names of all Customers who were in attendance at the meal and the business purpose of the meal. Orion: For all calls and programs, ensure that all attendees are captured and the meal is categorized. Field Action: Speak with your manager to confirm your Annual Per-Customer Spending Limit, and ensure you plan your activities to stay within the limit.
10 Product and Reimbursement Discussions Standard: This Standard also addresses, without limitation, product and reimbursement discussions by Field-Based Employees that arise in the following contexts: Discussions about disease states Responding to Customer questions Contracting discussions Sampling Discussions about participation in clinical studies Discussions about patient assistance programs Field-Based Employees Discussions: All Field-Based Employees discussions about Amgen products must be consistent with the approved prescribing information. Only material that is approved for promotional use may be used in connection with these discussions. Regional Medical Liaison Discussions: Field-Based Employees may engage RMLs to address specific unsolicited questions that require a greater depth of clinical expertise, or information Field-Based Employees have not been authorized to use in discussions with Customers. RML discussions are governed by the US Standard for Regional Medical Liaison Discussions. Field-Based Employees may never call upon RMLs to promote Amgen products in a manner that is inconsistent with approved product labeling. GEM and CAM Discussions: GEM and CAM employees are permitted to have materials at their disposal for discussing reimbursement matters with payors, with the designation that the materials are for GEM and/or CAM use only, as appropriate. GEM and CAM employees must take care to ensure their discussions with payors are accurate, and within the boundaries authorized by the home office. Product Promotion Field Materials Classification: Class I Promotional Materials, Disease State Education and Basic Reimbursement Pieces: Class I materials may be shown to Customers and, quantities permitting, left behind. Class II For Responsive Use Only: This material may be shown to Customers only in response to a specific, unsolicited request for the information contained in this piece. This material may not be used for product detailing, and may not be left behind.
11 Class III For Dissemination Only: These materials may be given to Customers, but they may not be discussed in any way (e.g., approved articles). On a later sales call, if the Customer asks a question, these materials may be used to answer the question. Class IV For Use, But Not Dissemination: Includes any contract performance sheets and proprietary pricing and sales information related to a specific Customer. May be used proactively with Customers, but because they include proprietary information they may not be distributed or left behind. Class V For Internal Use Only: These materials may not be used with Customers. They include sales training materials, and interest only articles to provide Field-Based Employees with background information about the products they sell. Specific Requirements for Reimbursement Discussions with purchasers: Field-Based Employees must emphasize that prescribing decisions should always be based on safety, efficacy and appropriateness for each patient and may not discuss reimbursement topics beyond the scope of the approved materials. Consequently, unless addressed in the approved materials, Field-Based Employees must not discuss reimbursement for competing products. Further, Field-Based Employees may never discuss how much money a Customer can make on the difference between the Customer s acquisition cost and reimbursement from Medicare or other third party payors (e.g., spread, profit, return to practice or other similar concept). Discussions About Disease States: When discussing disease state materials, Field-Based Employees must use only approved materials, and not affirmatively mention products unless: The materials allow for the discussion of product. The product discussion, when combined with the disease state educational material, would not suggest use of an Amgen product that is inconsistent with approved product labeling. Answering Customer Questions: Field-Based Employees should ensure their answers to Customer questions about safety and efficacy are consistent with the approved prescribing information. If an answer requires information that is inconsistent with the approved prescribing information, the Field-Based Employee may give the answer to the Customer under the following circumstances: Specific and Unsolicited: The question must be a genuine question that has not been prompted by the Field-Based Employee in any way. The question must also be sufficiently specific to warrant a response that provides data. The answer must be narrowly tailored to address only the question asked. It is inappropriate to volunteer additional information.
12 Use of Approved Materials: Only materials that have been approved for this purpose may be used to answer unsolicited Customer questions. If the question cannot be answered using approved materials, it may not be answered, and the Customer should be referred to the Medical Information Department. Fair Balance and Safety Information: Similar to promotional discussions, Field-Based Employees must ensure their answers to specific unsolicited Customer questions present a full and accurate description of all necessary safety information. Contracting Discussions: Field-Based Employees are not authorized to change the terms of contracts or to sign agreements and may not offer anything of value to Customers in connection with entering into a purchase contract. Field-Based Employees must not discuss reimbursement for competing products or how much money a Customer can make on the difference between the Customer s acquisition cost and reimbursement from Medicare or third-party payors (e.g., spread, profit, return to practice or other similar concept). Samples: Field-Based Employees who have been authorized to do so may provide samples to Customers in accordance with sampling initiatives led by the brand team. Participation in Clinical Studies: If a Customer would like to participate in a clinical trial, he or she must be referred to the appropriate RML. Field-Based Employees may not discuss clinical trials with Customers. The opportunity to participate in clinical trials may never be used as a tool for promoting Amgen products. Patient Assistance Programs: Patient assistance programs are strictly for the benefit of patients who qualify. Field-Based Employees may deliver home office-approved educational brochures to educate Customers about these programs. Field- Based Employees may not position these programs as a benefit to Customers, or as a reason to prescribe Amgen products. Field Action: Follow the guidelines as stated.
13 Promotional Speaker Programs Standard: All programs where Amgen employees and agents (e.g., a vendor that manages speaker programs) arrange for a speaker to present information on behalf of the company are considered speaker programs. Speaker programs are promotional events. Speaker Program Content: Speaker program topics must be relevant to Amgen s business and/or products. Speaker programs must be delivered from slide kits that have been approved in advance by the appropriate pink folder team. Product Program Topics: Speaker programs discussing Amgen marketed products must present only information that is consistent with an FDA-approved indication for a marketed product. Disease State Program Topics: Speaker program topics may also address disease states that are of interest to Amgen. Disease state programs should focus on the particular disease or condition. Business Program Topics: Speaker programs may also discuss limited business topics that are directly related to Amgen s products (e.g., coverage and coding issues related to Amgen products). Speaker programs may not be used to provide consulting services to Customers. Attendance: Speaker programs are only appropriate where at least four (4) targeted healthcare professionals are expected to attend, and shall be open to invited healthcare professionals only. Spouses or other guests of attendees may not be invited or accommodated. The company does not reimburse attendees travel and other expenses. Arrangements with Speakers: Speakers must be trained members of the appropriate Amgen Speaker Bureau with a valid contract that includes an agreement to adhere to Amgen s Speaker Rules. Selection of a speaker from the Speaker Bureau must be based upon the speaker s qualifications, skill and geographic location. Speakers may not be selected on the basis of their prescribing patterns, or their potential to generate future business. Speaker Programs
14 Field Action: Persons wishing to conduct a speaker program shall submit a request to Medical Education no later than four (4) weeks in advance of the planned event. The person requesting the program shall be considered the Responsible Amgen Employee (RAE). The RAE is responsible for ensuring that any meals connected to a speaker s program comply with the Meals Standard. Invitations: Invitations to speaker programs must be generated from a template that has been approved in advance by the appropriate pink folder team. Field Personnel Involvement at Meeting: The RAE should attend the speaker program. Amgen employees should refrain from engaging in the program discussion. If they do engage, all statements are considered promotional, and must be consistent with the package insert for the product being discussed. Field Monitoring of Individual Speaker Programs: The RAE is responsible for ensuring the speaker program is conducted in compliance with this Standard. If a speaker fails to follow these rules, the RAE shall report the failure to his or her manager. The manager and the RAE should work with speakers to correct occasional lapses. If a speaker repeatedly fails to follow Amgen s Rules Governing Speakers, the RAE and the manager must: Stop using the speaker immediately. Inform the brand team that the speaker should be removed from the Speaker Bureau. Orion: For all promotional speaker programs, ensure that all attendees are captured.
15 Marketing Standards Advisory Boards An Advisory Board is a small group of experts convened to advise Amgen on research, commercial and/or product development strategy issues. Advisory Boards shall be conducted solely for the purpose of obtaining necessary medical, scientific or commercial advice. Advisory Boards may not be conducted for the purpose of promoting Amgen s products or pipeline or for providing education or training to advisors. Advisory boards may not be conducted by members of the sales organization. Advisors must be selected solely for their expertise and ability to provide meaningful advice on the topic(s) identified. Advisors may not be selected on the basis of their prescribing patterns, or their potential to generate future business. Advisors shall be paid Fair Market Value for their participation in an Advisory Board. For commercial advisory boards, Marketing, with the assistance of Amgen Clinical Development and Medical Affairs, will be responsible for the selection of Advisors. Sales staff may not participate in any process for selecting Advisors. The number of Amgen attendees shall be limited to the Amgen personnel necessary to the conduct of the meeting. In general, attendance by Marketing should be limited to the RAE and others who have clearly defined roles. Members of the Sales Department should not attend unless their attendance has been approved in connection with the approval for the concept of the meeting. Advertising, Exhibit Space, Joint Marketing and Other Communication Arrangements with Customers This Standard covers arrangements where Amgen purchases the right to promote its products at a Customer-sponsored event. Amgen may only enter into a communication arrangement with a Customer for a legitimate Amgen need to increase awareness of its current or prospective products. Healthcare professionals and other Customers selected for such arrangements must be well qualified, in terms of education and experience, and, if applicable, available facilities. Under no circumstances may a payment be offered or provided with the intent of, directly or indirectly, influencing or encouraging the recipient to purchase, prescribe, refer, sell, arrange for the purchase or sale, or recommend formulary placement of any Amgen product. Marketing Standards
16 Arrangements may not be offered in connection with discussions, negotiations, or decisions involving product pricing or purchasing, or formulary decisions. Sales personnel will not generally arrange for these events, but they may be asked to participate in a promotional capacity. When requested to participate in these events, sales personnel should follow all instructions from headquarters. Any promotional items to be given away at Customer-sponsored events must comply with the Amgen Standard for Gifts to Healthcare Professionals. Discounts Amgen will only offer those discounts, rebates and GPO Administrative Fees that comply with the requirements of all applicable federal and state laws, including but not limited to the federal anti-kickback statute. These arrangements must also comply with applicable antitrust laws. All discounting arrangements must be documented in advance in an agreement that is approved by the Law Department. Amgen will not tolerate any business transaction or activity that violates the letter or spirit of the antitrust and competition laws of any country in which Amgen conducts business. Headquarters-based staff will work with the Law Department to develop product purchase agreements that meet the requirements of this standard. Sales personnel may offer product purchase contracts if authorized to do so by headquarters. Sales personnel may not negotiate or otherwise alter the terms of these agreements. Service Agreements Sometimes Amgen has a need to purchase services from healthcare professionals and other Customers. When Amgen has such a need, it must enter into a service agreement that meets the requirements of the Service Agreement Standard. Service agreements with Customers must meet a legitimate Amgen business need. Service providers must be well qualified, in terms of education and experience, and, if applicable, available facilities. Compensation may not exceed the fair market value of services provided. Under no circumstances may a service agreement be offered or provided with the intent of, directly or indirectly, influencing or encouraging the recipient to purchase, prescribe, refer, sell, arrange for the purchase or sale, or recommend formulary placement of any Amgen product. Service agreements may not be offered in connection with discussions, negotiations, or decisions involving product pricing or purchasing, or formulary decisions.
17 Sales personnel should not enter into service agreements with Customers. Sales personnel who receive a Customer request to provide services to Amgen should refer the Customer to the appropriate Director of Marketing. The Director of Marketing will work with the Law Department and the Compliance Officer as necessary to determine whether Amgen has a need to purchase the services. Speaker Bureaus Promotional speaker programs play an important role in the marketing of Amgen products. Healthcare professionals who speak on behalf of Amgen have the ability to engage an audience of their peers in a more meaningful dialogue than may be possible through most other promotional methods. This, in turn, leads to Customers having a better understanding of the appropriate use of Amgen products. When healthcare professionals speak on behalf of Amgen, they are considered agents of Amgen. They must represent the company well, and their presentations must comply with the Food and Drug Administration (FDA) regulations concerning product promotion. In addition, Amgen s arrangements with its speakers will comply with the PhRMA Code, as well as the principles set forth in the OIG Compliance Program Guidance for Pharmaceutical Manufacturers. This Standard is intended to ensure that Amgen s dealings with external speakers, as well as the services they perform on behalf of the company, will meet these requirements. The Marketing Department will follow the Speaker Bureau Standard in conducting and managing Amgen Speaker Bureaus. Sales personnel shall consult the Speaker Program Standard when arranging speaker programs with members of an Amgen Speaker Bureau.
18 Amgen Inc. One Amgen Center Drive Thousand Oaks, CA Amgen Inc. All rights reserved. P50486/Rev
PhRMA Code on Interactions with Healthcare Professionals
PhRMA Code on Interactions with Healthcare Professionals Preamble The Pharmaceutical Research and Manufacturers of America (PhRA4.A) represents research-basedpharmaceutical and biotechnology companies.
More informationKeeping our Focus: Compliance Summary for Customers and Health Care Professionals. Understanding the Olympus Health Care Compliance Code of Conduct
Keeping our Focus: Compliance Summary for Customers and Health Care Professionals Understanding the Olympus Health Care Compliance Code of Conduct Introduction Olympus Corporation of the Americas ( Olympus
More informationCONDUCTING BUSINESS WITH HEALTH CARE PROFESSIONALS.
A. General. CONDUCTING BUSINESS WITH HEALTH CARE PROFESSIONALS. This policy governs the interactions between Company personnel and health care professionals. The term health care professional means any
More informationCode on Interactions with Healthcare. Professionals
Code on Interactions with Healthcare Professionals Table of Contents Preamble 1 Basis of Interactions 2 Informational Presentations by Pharmaceutical Company Representatives and Accompanying Meals 3 Prohibition
More informationU.S. PHARMACEUTICALS COMPLIANCE AND ETHICS CODE OF CONDUCT
U.S. PHARMACEUTICALS COMPLIANCE AND ETHICS CODE OF CONDUCT Effective: January 1, 2009 U.S. PHARMACEUTICALS COMPLIANCE AND ETHICS CODE OF CONDUCT January 1, 2009 I. INTRODUCTION Table of Contents II. COMPLIANCE
More informationSUCAMPO PHARMA AMERICAS, LLC COMPREHENSIVE COMPLIANCE PROGRAM
SUCAMPO PHARMA AMERICAS, LLC COMPREHENSIVE COMPLIANCE PROGRAM 1. Introduction It is the policy of Sucampo Pharma Americas, LLC, ( Sucampo or Company ) to promote our products in full compliance with law,
More informationEffective March 23, 2015
I. Goal and Scope CODE OF ETHICS ON INTERACTIONS WITH HEALTH CARE PROFESSIONALS Effective March 23, 2015 Symmetry Surgical Inc. ( Symmetry ) has an obligation to facilitate ethical interactions between
More informationAmgen GLOBAL CORPORATE COMPLIANCE POLICY
1. Scope Applicable to all Amgen Inc. and subsidiary or affiliated company staff members, consultants, contract workers and temporary staff worldwide ( Covered Persons ). Consultants, contract workers,
More informationMA Healthcare Reform Legislation: Assessment of Massachusetts Department of Public Health Regulations
MA Healthcare Reform Legislation: Assessment of Massachusetts Department of Public Health Regulations Pri-Med Institute Marissa Seligman, PharmD mseligman@pri-medinstitute.org DISCLAIMER: For informational
More informationThe Chairman s Message on Health Care Compliance
904438_JnJ_EmpGde 9/17/09 8:37 AM Page FC2 The Chairman s Message on Health Care Compliance Johnson & Johnson is known the world over for innovative, life-saving medical products and for the values we
More informationA PASSION FOR INTEGRITY. Every Day Health Care Compliance. Code of Conduct
A PASSION FOR INTEGRITY Every Day Health Care Compliance Code of Conduct Health Care Compliance Is Everyone s Responsibility Johnson & Johnson Pharmaceutical Affiliates are known the world over for innovative,
More informationBayer HealthCare s Comprehensive Compliance Program Pursuant to California Health and Safety Code 119400-119402
Bayer HealthCare s Comprehensive Compliance Program Pursuant to California Health and Safety Code 119400-119402 I. INTRODUCTION Bayer HealthCare LLC [including Bayer HealthCare LLC Dermatology Division
More informationEucomed. Code of Ethical Business Practice. Eucomed Guidelines on Interactions with Healthcare Professionals
Eucomed M e d i c a l T e c h n o l o g y Code of Ethical Business Practice Eucomed Guidelines on Interactions with Healthcare Professionals Amended September 2008 - Board approved, 11 September 2008 The
More information3. HEALTH, SAFETY AND ENVIRONMENTAL PROTECTION
1. PURPOSE It is the goal of UCB, Inc. (UCB) to ensure that its marketing and promotional activities comply with all applicable state and federal laws. In addition, UCB Inc. endeavors to conform to pertinent
More informationMA Healthcare Reform Legislation: Overview of Massachusetts Department of Public Health Regulations
MA Healthcare Reform Legislation: Overview of Massachusetts Department of Public Health Regulations Melissa J. Lopes, Deputy General Counsel Massachusetts Department of Public Health Marissa Seligman,
More informationGlobal Policy on Interactions with Healthcare Professionals
Global Policy on Interactions with Healthcare Professionals Global Policy on Interactions with Healthcare Professionals Pfizer is committed to collaborating with physicians and other healthcare professionals,
More informationThe scope of beneficial interactions between Health Care Professionals and Companies is broad and includes interactions intended to:
CODE OF ETHICS ON INTERACTIONS WITH HEALTH CARE PROFESSIONALS ADOPTED BY THE ADVANCED MEDICAL TECHNOLOGY ASSOCIATION I. Preamble: Goal and Scope of AdvaMed Code The Advanced Medical Technology Association
More informationHeraeus Medical Code of Conduct on Interactions with Health Care Professionals
Heraeus Medical Code of Conduct on Interactions with Health Care Professionals effective 13 th July 2009 The Heraeus Medical Code of Conduct is based on the Advamed Code of Ethics and influenced by Codes
More informationPOLICY ON INTERACTIONS WITH HEALTHCARE PROFESSIONALS
POLICY ON INTERACTIONS WITH HEALTHCARE PROFESSIONALS Table of Contents Interaction with Healthcare Professionals... 2 Definitions... 2 Basic Requirements for all Interactions with Healthcare Professionals...
More informationUniversity of Miami Miller School of Medicine
University of Miami Miller School of Medicine Policy UMMG [University of Miami Medical Group] Policy: Pharmaceutical/Device Representative Interaction Division of Continuing Medical Education Website Date
More informationCode of Conduct. Compliance W.I.N.S Worldwide Integrity is Necessary for Success
Code of Conduct Compliance W.I.N.S Worldwide Integrity is Necessary for Success Effective February 2014 Disclaimer BEFORE YOU BEGIN You are being provided this certification to assist you in meeting your
More informationMarshall University Joan C. Edwards School of Medicine Conflict of Interest Policy. Introduction
Marshall University Joan C. Edwards School of Medicine Conflict of Interest Policy Introduction The faculty 1 and medical students of the Joan C. Edwards School of Medicine (SOM) have responsibilities
More informationPolicy for Managing Private Healthcare Industry* (PHCI) Interactions at the UNM HSC Clinical Care and Educational Missions**
Policy for Managing Private Healthcare Industry* (PHCI) Interactions at the UNM HSC Clinical Care and Educational Missions** Approved by the SOM Committee of Chairs January 23, 2008. Approved by the COP
More informationUniversity of Cincinnati College of Medicine
University of Cincinnati College of Medicine Policy Policy and Guidelines for Industry Relationships Policy and Guidelines for Industry Relationships FAQ Date Updated Page 5/14/2008 2 -- 8 NB: The Institute
More informationUniversity of Central Florida College of Medicine Industry Relations Policy and Guidelines. Table of Contents
University of Central Florida College of Medicine Industry Relations Policy and Guidelines 1. Introduction and Scope of Policy 2. Statement of Policy Table of Contents 3. Gifts and Individual Financial
More informationIn-house code: Specific guidelines regarding a company s own promotion. All members are requested to formulate an in-house code.
Comparison of the AdvaMed Code of Ethics and the Japanese JFMDA Promotion Code Executive Summary: The Japan Federation of Medical Devices Associations, (JFMDA), consists of some 20 associations representing
More informationThe Ohio State University Medical Center Vendor Interaction Policy Approved OSUMC Executive Cabinet, March 12, 2009 Policy effective July 1, 2009
The Ohio State University Medical Center Vendor Interaction Policy Approved OSUMC Executive Cabinet, March 12, 2009 Policy effective July 1, 2009 Purpose All healthcare professionals and institutions have
More informationGlobus Medical, Inc. Code of Ethics
Globus Medical, Inc. Code of Ethics 1. Introduction In performing their duties for Globus Medical, Inc. ( Globus ), each employee shall maintain the highest standards of honest and ethical conduct in all
More informationBrief Summary of the National Physician Payment Transparency Program: Open Payments Physician Payment Sunshine Act
Brief Summary of the National Physician Payment Transparency Program: Open Payments Physician Payment Sunshine Act (Prepared by the Department of Health Policy and Regulatory Affairs, February 26, 2013)
More informationCORNERSTONE THERAPEUTICS INC. SECOND AMENDED AND RESTATED CODE OF BUSINESS CONDUCT AND ETHICS
CORNERSTONE THERAPEUTICS INC. SECOND AMENDED AND RESTATED CODE OF BUSINESS CONDUCT AND ETHICS This Second Amended and Restated Code of Business Conduct and Ethics (the Code ) sets forth legal and ethical
More informationTitle: Gifts and Business Courtesies
Title: Gifts and Business Courtesies Effective Date: 5/04; Rev. 5/07 POLICY: Employees, (referred to as associates at some affiliates) officers and members of the Boards of Directors of Iowa Health System
More informationBoard Statute Regarding Gifts to Physicians
Board Statute Regarding Gifts to Physicians KRS 311.595(9), as illustrated by KRS 311.597(4), provides that it is a statutory violation, and a basis for disciplinary action against a license, for a licensed
More informationState Marketing Law Compliance: Implications of Federal Sunshine Act Preemption
State Marketing Law Compliance: Implications of Federal Sunshine Act Preemption Ronald L. Wisor, Partner February 19, 2013 Health / United States Agenda Types of state marketing laws State-specific requirements
More informationGoodyear s Anti-bribery Policy July 1, 2011
Goodyear s Anti-bribery Policy July 1, 2011 Anti-bribery Policy Goodyear does not wish to obtain business advantages by offering or receiving improper payments or anything of value, even in countries where
More informationADVAMED CODE OF ETHICS. Illustrative Best Practices Tools
ADVAMED CODE OF ETHICS Illustrative Best Practices Tools ADVAMED CODE OF ETHICS Illustrative Best Practices Tools Menu Charitable Donations Consulting Arrangements Demonstration and Evaluation Units Educational
More informationHealthcare Law Compliance Policies
Healthcare Law Compliance Policies Compliance Hotline: 1-877-PURDUE1 (1-877-787-3831) Purdue Pharma L.P. and Associated U.S. Companies Dear Colleagues, Purdue (the Company) is committed to complying with
More informationWhy do we have Speaker Compliance Guidelines and Training?
Disclaimer The views expressed in this presentation are the views of the facilitators and do not necessarily represent the views or policies of our employer. Why do we have Speaker Compliance Guidelines
More informationSUMMARY OF COMPREHENSIVE COMPLIANCE PROGRAM
1. Introduction SUMMARY OF COMPREHENSIVE COMPLIANCE PROGRAM The Medicines Company (the Company ) is committed to establishing and maintaining an effective compliance program that promotes ethical conduct
More informationGuidance Document Questions & Answers (Q&As) on the MedTech Europe Code of Ethical Business Practice
Guidance Document Questions & Answers (Q&As) on the MedTech Europe Code of Ethical Business Practice INTRODUCTION Aims and Principles of the Code 2 December 2015 Q1: Does the definition of Healthcare Professional
More informationFraud, Abuse, and The AdvaMed Code
Fraud, Abuse, and The AdvaMed Code Essentials of Medical Device Regulations Bethesda, Maryland May 14, 2008 Elizabeth Carder-Thompson Washington DC ecarder@reedsmith.com 202.414.9213 Agenda Introduction
More informationPROMIUS PHARMA, LLC Guide to North America Healthcare Compliance
PROMIUS PHARMA, LLC Guide to North America Healthcare Compliance 2015 Promius Pharma, LLC NOTICE: this information is provided pursuant to the requirements of California Health & Safety Code 119400, 119402,
More informationCODE OF ETHICS AND CONDUCT
CODE OF ETHICS AND CONDUCT BSN medical S.r.l. Capital 10,000.00, fully paid-in Single-Member Company - Monza and Brianza Economic Administrative Repertoire 1801972 Monza and Brianza Register of Companies,
More informationTravel Program & Business Expense Policy Business Ethics & Vendor Relationships FAQs
CORPORATE POLICY CREATED: REVIEWED: REVISED: Business Ethics and Vendor Relationships SCOPE: All Employees APPROVED BY: Corporate Leadership Team (CLT) FORMULATED BY: Chief Compliance Officer Reference
More informationEMORY UNIVERSITY SCHOOL OF MEDICINE POLICY ON INDUSTRY AND OTHER EXTERNAL PROFESSIONAL RELATIONSHIPS. Table of Contents
EMORY UNIVERSITY SCHOOL OF MEDICINE POLICY ON INDUSTRY AND OTHER EXTERNAL PROFESSIONAL RELATIONSHIPS Table of Contents EMORY UNIVERSITY SCHOOL OF MEDICINE POLICY ON INDUSTRY AND OTHER EXTERNAL PROFESSIONAL
More informationGUIDE TO VERMONT S PRESCRIBED PRODUCTS LAW FOR FY10 DISCLOSURES Published by the Vermont Office of the Attorney General 11/5/2009
Introduction GUIDE TO VERMONT S PRESCRIBED PRODUCTS LAW FOR FY10 DISCLOSURES Published by the Vermont Office of the Attorney General 11/5/2009 Effective July 1, 2009, Vermont law bans certain gifts and
More informationINTEGRITY IN ACTION - HEALTH CARE COMPLIANCE
A PASSION FOR INTEGRITY INTEGRITY IN ACTION - HEALTH CARE COMPLIANCE HEALTH CARE COMPLIANCE IS EVERYONE S RESPONSIBILITY DePuy Synthes is known the world over for innovative, life enhancing orthopedic
More informationFDA & Life Sciences Practice Group. State Marketing Laws Impacting Medical Device Manufacturers. January 11, 2010
State Marketing Laws Impacting Medical Device Manufacturers January 11, 2010 For more information, contact: Seth Lundy (202) 626-2924 slundy@kslaw.com Nikki Reeves (202) 661-7850 nreeves@kslaw.com Elizabeth
More informationEmory Healthcare Policy on Relationships with Vendors, Industry and Other External Professional Relationships
Final Version 1,12,2010 Emory Healthcare Policy on Relationships with Vendors, Industry and Other External Professional Relationships 1. Scope 2. Overview 3. Applicability 4. General Policy 5. Gifts/Donations
More informationU.S. SALES & MARKETING CODE OF CONDUCT. Do the Right Thing
U.S. SALES & MARKETING CODE OF CONDUCT Do the Right Thing table of contents DJO Global Incorporated requires its sales and marketing personnel to observe high standards of integrity and honesty, and to
More informationHow to Conduct a Clinical Research Compliance Assessment
8 th Annual Pharmaceutical Regulatory Compliance Congress Track II Session November 8, 2007 How to Conduct a Clinical Research Compliance Assessment Elizabeth Jobes Deputy Compliance Officer Cephalon,
More informationHCCA 2013 COMPLIANCE INSTITUTE ANTI-KICKBACK STATUTE 101 SEATTLE, WASHINGTON
UW MEDICINE HCAA 2013 Compliance Institute HCCA 2013 COMPLIANCE INSTITUTE ANTI-KICKBACK STATUTE 101 April 23, 2013 Robert S. Brown Senior Compliance Specialist UW Medicine Compliance SEATTLE, WASHINGTON
More information07.02 Texas Higher Education Fair Lending Practices
07.02 Texas Higher Education Fair Lending Practices Approved September 28, 2007 (MO 234-2007) Revised August 8, 2013 (MO 192-2013) Next Scheduled Review: August 8, 2018 Policy Statement The Texas Higher
More informationCODE OF ETHICS AND PROFESSIONAL CONDUCT
CODE OF ETHICS AND PROFESSIONAL CONDUCT Mission To provide adults, caregivers and families with programs and services promoting an enhanced quality of life. Family Alliance, Inc. has a clearly stated charitable
More informationLIBRARY GUIDE: Pharmaceutical Sales & Marketing
LIBRARY GUIDE: Pharmaceutical Sales & Marketing Page 2 Pharmaceutical Sales and Marketing Course Library Table of Contents: Courses Listed by Functional Area... 4 Basics of the PhRMA Code (PHSM01)...5
More informationBlowing the Whistle on Healthcare Fraud
Blowing the Whistle on Healthcare Fraud Healthcare Purchasing News, July, 2004 by Kenneth J. Nolan Medical technology is crucial to the health and welfare of our citizens. The industry provides us with
More informationLIBRARY GUIDE: Medical Device Sales & Marketing
LIBRARY GUIDE: Medical Device Sales & Marketing Page 2 Table of Contents Overview... 2 About Our Health Care Compliance Solution... 2 Our Relationship With AdvaMed... 2 Course Descriptions: Basics of the
More informationNavigating the Maze of State Laws and Advertising & Promotion
Navigating the Maze of State Laws and Advertising & Promotion By Linda Pollitz, RAC 10 November 2009 Scenario Imagine you are a regulatory professional at an orthopedic product company. You sit on a legal/
More information1.3 There have been no material or substantive changes to the Code since last year.
1. Please describe the key components of the GPO s written code of business ethics and conduct. (Please provide a copy and describe any changes since the last submission.) Please assure your response includes:
More informationSummary. ViiV Healthcare Compliance Program U.S. Operations
ViiV Healthcare Compliance Program U.S. Operations Summary ViiV Healthcare Company (the Company or VH ) is committed to conducting its business with honesty and integrity, and with high standards for ethical
More informationLaw Department Policy No. L-1 Title:
I. SCOPE: Law Department Policy No. L-1 Page: 1 of 6 This policy applies to (1) Tenet Healthcare Corporation and its wholly-owned subsidiaries and affiliates (each, an Affiliate ); (2) any other entity
More informationTravel and Entertainment Policy. Introduction and Purpose. Purpose
Introduction and Purpose Purpose It is Colliers International s (Company) policy that employees be reimbursed for all appropriate and approved travel, entertainment and other expenses incurred when conducting
More informationDUVAL CLIENT ALERT December 2009
1 P a g e DUVAL CLIENT ALERT December 2009 In this DUVAL CLIENT ALERT, we list practical ways medical device companies can lawfully communicate about their products prior to FDA clearance or approval.
More informationUniversity of Wisconsin Colleges Administrative Policy #52 POLICY ON RELATIONSHIPS WITH STUDENT LOAN LENDERS. Table of Contents. Introduction...
University of Wisconsin Colleges Administrative Policy #52 POLICY ON RELATIONSHIPS WITH STUDENT LOAN LENDERS Implemented: 8/1/2008 Approved by Chancellor: 7/31/08 Approved by Provost: 5/1/2008 Reviewed
More informationCode of Business Practice
Code of Business Practice Mecomed Guidelines on Interactions with Healthcare Professionals Board approved, November 1 st, 2008 Amended version, May 2015 The MECOMED Code of Business Practice consists of
More informationOrange Guide (also known as the Field Guide)
Pfizer Inc 235 East 42nd Street New York, NY 10017 www.pfizer.com Dear Colleagues: At Pfizer, we are committed to upholding the highest standards when we interact with physicians, healthcare organizations,
More informationIntroduction. Plan sponsors include employers, unions, trust funds, associations and government agencies, and are also referred to as payors.
Maintaining the Affordability of the Prescription Drug Benefit: How Managed Care Organizations Secure Price Concessions from Pharmaceutical Manufacturers Introduction The purpose of this paper is to explain
More informationClause 2 (Contractual Arrangements)
Questions and Answers (Q&A) Relating to the International Medical Device Manufacturers Association (IMEDA) Code of Ethical Conduct for Interactions with Healthcare Professionals Clause 2 (Contractual Arrangements)
More informationHealthcare Law Compliance Guide (commonly known as the White Guide)
Pfizer Inc 235 East 42nd Street New York, NY 10017 www.pfizer.com Dear Colleagues: At Pfizer, we are committed to upholding the highest standards when we interact with physicians, healthcare organizations,
More informationCORPORATE INTEGRITY AGREEMENT
CORPORATE INTEGRITY AGREEMENT BETWEEN THE OFFICE OF INSPECTOR GENERAL OF THE DEPARTMENT OF HEALTH AND HUMAN SERVICES AND GLAXOSMITHKLINE LLC I. PREAMBLE (GSK) hereby enters into this Corporate Integrity
More informationFormulary Management
Formulary Management Formulary management is an integrated patient care process which enables physicians, pharmacists and other health care professionals to work together to promote clinically sound, cost-effective
More informationCONDUCTING BUSINESS WITH CVS HEALTH
CONDUCTING BUSINESS WITH CVS HEALTH As a vendor/supplier to one or more affiliates of CVS Health, you and your company play an integral part in our success as a pharmacy innovation company. Therefore,
More informationSTONY BROOK UNIVERSITY HOSPITAL GRADUATE MEDICAL EDUCATION POLICIES AND PROCEDURES PHARMACEUTICAL VENDOR/CORPORATION RELATIONSHIPS
1 STONY BROOK UNIVERSITY HOSPITAL GRADUATE MEDICAL EDUCATION POLICIES AND PROCEDURES POLICY: PHARMACEUTICAL VENDOR/CORPORATION RELATIONSHIPS PURPOSE To establish an institutional policy regarding institutional
More informationCONCORDIA HEALTHCARE CORP. CODE OF CONDUCT. Message from the Chairman and Chief Executive Officer ( CEO )
CONCORDIA HEALTHCARE CORP. CODE OF CONDUCT Message from the Chairman and Chief Executive Officer ( CEO ) Dear Colleagues, The standards of ethical excellence that Concordia was founded upon remain as important
More informationPHARMACY BENEFIT DESIGN CONSIDERATIONS
PHARMACY BENEFIT DESIGN CONSIDERATIONS Is your pharmacy benefit designed for your employees or the big drug companies? The pharmacy (or prescription) benefit is one of the most sought after benefits by
More informationGUIDELINES FOR PHYSICIANS IN INTERACTIONS WITH INDUSTRY
CMA POLICY GUIDELINES FOR PHYSICIANS IN INTERACTIONS WITH INDUSTRY The history of health care delivery in Canada has included interaction between physicians and the pharmaceutical and health supply industries;
More informationThe Hidden Costs of Free Lunches: Fraud and Abuse in Physician- Pharmaceutical Arrangements
The Hidden Costs of Free Lunches: Fraud and Abuse in Physician- Pharmaceutical Arrangements Alice G. Gosfield* W hen it comes to physician-pharmaceutical manufacturer relationships, the old adage there
More informationLegal Considerations in Marketing Practices
Author: Attorney Dan A. Riegleman N63 W23965 Main Street Sussex, Wisconsin 53089 Prepared: 06/01/10 WHITE PAPER: DR2518 Legal Considerations in Marketing Practices Chiropractors, like all healthcare service
More informationDeductible Business Expenses Guide
Rent Any expense related to the use of real estate or any other kind of property that is not owned by your business, but is used in the operation of your business. These expenses are 100% deductible, if
More informationList of Guiding Principles Promoting Good Governance in the Pharmaceutical Sector 1
List of Guiding Principles Promoting Good Governance in the Pharmaceutical Sector 1 1. Good governance in the pharmaceutical sector 1.1 The List of Guiding Principles is based on recognition by all participants
More informationVANDA PHARMACEUTICALS INC.
VANDA PHARMACEUTICALS INC. CODE OF ETHICS AND BUSINESS CONDUCT (As of May 22, 2014) 1. POLICY STATEMENT The reputation and integrity of Vanda Pharmaceuticals Inc. (the Company ) are valuable assets that
More informationOffice of Inspector General. Compliance Program Guidance for Pharmaceutical Manufacturers
Office of Inspector General Compliance Program Guidance for Pharmaceutical Manufacturers April 2003 2 Office of Inspector General s Compliance Program Guidance for Pharmaceutical Manufacturers I. Introduction
More information2. All Island Health CME/PD activities must be free of any real or perceived commercial bias.
[Type Island Health Guidelines for Commercial Support of Continuing Medical Education/Continuing Professional Development Activities The following document outlines the guiding principles pertaining to
More informationWhat is a Compliance Program?
Course Objectives Learn about the most important elements of the compliance program; Increase awareness and effectiveness of our compliance program; Learn about the important laws and what the government
More informationUr-Energy Inc. Code of Business Conduct and Ethics
Ur-Energy Inc. Code of Business Conduct and Ethics As Amended Effective February 5, 2014 2957409.2 TABLE OF CONTENTS INTRODUCTION... 3 CONFLICTS OF INTEREST... 3 GIFTS, INVITATIONS AND ENTERTAINMENT GUIDELINES...
More informationMedicare Advantage and Part D Fraud, Waste, and Abuse Training. October 2010
Medicare Advantage and Part D Fraud, Waste, and Abuse Training October 2010 Introduction 2008: United States spent $2.3 trillion on health care. Federal fiscal year 2010: Medicare expected to cover an
More informationInterim Commissioner Lauren A. Smith, MD, MPH and Members of the Public Health Council
DEVAL L. PATRICK GOVERNOR TIMOTHY P. MURRAY LIEUTENANT GOVERNOR JUDYANN BIGBY, MD SECRETARY LAUREN A. SMITH, MD, MPH INTERIM COMMISSIONER TO: The Commonwealth of Massachusetts Executive Office of Health
More informationGlobal Compliance Programme Operational Issues: Infrastructure, Monitoring, Auditing and Managing with Limited Resources
Global Compliance Programme Operational Issues: Infrastructure, Monitoring, Auditing and Managing with Limited Resources Julien Durand Director, Global Compliance Implementation, AstraZeneca PLC, London
More informationUnder section 1128A(a)(5) of the Social Security Act (the Act), enacted as part of
OFFICE OF INSPECTOR GENERAL SPECIAL ADVISORY BULLETIN OFFERING GIFTS AND OTHER INDUCEMENTS TO BENEFICIARIES August 2002 Introduction Under section 1128A(a)(5) of the Social Security Act (the Act), enacted
More informationA Handbook for Planning Committees Developing Educational Programs
A Handbook for Planning Committees Developing Educational Programs Approved October 23, 2012 Educational Program Development Cycle Step 1 Convene planning committee Step 8 Review the evaluation results
More informationReporting of Transfers of Value to HCPs and HCOs Methodological Note for Reporting of 2015 Data in 2016
Reporting of Transfers of Value to HCPs and HCOs Methodological Note for Reporting of 2015 Data in 2016 AstraZeneca Österreich GmbH Schwarzenbergplatz 7, 1030 Wien Firmenbuch FN 51184x, HG Wien Contents
More informationPaul Appelbaum, Julio Arboleda-Flórez, Afzal Javed, Constantin Soldatos, Sam Tyano. WPA Standing Committee on Ethics
for relationships of psychiatrists, health care organizations working in the psychiatric field and psychiatric associations with the pharmaceutical industry Paul Appelbaum, Julio Arboleda-Flórez, Afzal
More informationFinancial Aid Code of Conduct
Financial Aid Code of Conduct Original Implementation: April 21, 2009 Last Revision: April 14, 2015 This code of conduct is promulgated under the Higher Education Act 487(a)(25), as reauthorized and amended
More informationFraud, Waste, and Abuse Training For Use By Care Wisconsin Providers Created: September 20, 2010 Reviewed/Revised: 8/18/2011
Fraud, Waste, and Abuse Training For Use By Care Wisconsin Providers Created: September 20, 2010 Reviewed/Revised: 8/18/2011 Definitions & Examples Why it Matters Prevention, Detection and Reporting Your
More informationdated February 16, 2004 (announced in the Federal Gazette of April 22, 2004 Federal Gazette (BAnz.) No. 76, page 8732)
Code of Conduct of the Members of the Organization Voluntary Self-regulation for the Pharmaceutical Industry ( VS Pharmaceutical Industry Code of Conduct) dated February 16, 2004 (announced in the Federal
More informationFair Market Value and Payments to Healthcare Professionals How Should We Determine What We Pay? Huron Consulting Services LLC. All rights reserved.
Fair Market Value and Payments to Healthcare Professionals How Should We Determine What We Pay? Huron Consulting Services LLC. All rights reserved. Contact Information Debjit Ghosh Life Sciences Practices
More informationWhy Worry? Fraud and Abuse Risks for Managed Care Organizations. Overview
Why Worry? Fraud and Abuse Risks for Managed Care Organizations Stephen K. Warch Shareholder, Nilan Johnson Lewis Overview Risks Created by Incentives Offered by Health Plans and Providers o Prohibition
More informationUNITED WAY OF GREATER GREENSBORO, INC. CODE OF ETHICS
UNITED WAY OF GREATER GREENSBORO, INC. CODE OF ETHICS The Board of Directors of the United Way of Greater Greensboro, Inc. (the Organization ) has adopted the following Code of Ethics, which applies to
More informationABC Process & Parameters
ABC Process & Parameters I. PURPOSE The purpose of these regulations is to provide basic guidelines for the sale, serving, supply and consumption of alcoholic beverages on University property. Alcoholic
More information800 17th Street, NW Suite 1100, Washington, DC 20006
800 17th Street, NW Suite 1100, Washington, DC 20006 September 3, 2015 Mr. Andrew Slavitt Acting Administrator, Centers for Medicare & Medicaid Services Department of Health and Human Services Hubert H.
More informationGUIDELINES FOR FUNDRAISING SPECIAL EVENTS
GUIDELINES FOR FUNDRAISING SPECIAL EVENTS Guidelines for Fundraising Special Events Thank you for your interest in supporting Community Hospice of Northeast Florida. In fulfillment of its mission, the
More information